• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

婴儿血管瘤的人口统计学和临床特征及危险因素:一项中国病例对照研究。

Demographic and clinical characteristics and risk factors for infantile hemangioma: a Chinese case-control study.

作者信息

Li Jie, Chen Xiang, Zhao Shuang, Hu Xing, Chen Chen, Ouyang Fang, Liu Queping, Ding Rong, Shi Qian, Su Juan, Kuang Yehong, Chang Jing, Li Fangfang, Xie Hongfu

机构信息

Department of Dermatology, Xiangya Hospital, Central South University, 87 Xiangya Rd, Changsha, Hunan, 410008, China.

出版信息

Arch Dermatol. 2011 Sep;147(9):1049-56. doi: 10.1001/archdermatol.2011.122. Epub 2011 May 16.

DOI:10.1001/archdermatol.2011.122
PMID:21576550
Abstract

OBJECTIVES

To study the demographic and clinical features of infantile hemangioma in China; to learn in more detail the risk factors for developing this disease; and to identify clinical characteristics associated with complications, associated risks, and the need for systemic treatment.

DESIGN

A case-control study of 1832 prospectively enrolled children with hemangiomas and 1832 controls matched for age, sex, region, and hospital attending the dermatology department between 2005 and 2008.

SETTING

Two large hospitals in central south China.

PATIENTS

A total of 1832 children with hemangiomas.

MAIN OUTCOME MEASURES

Demographic and clinical presentations were summarized and compared with data from previous studies of hemangiomas. Predictive clinical factors for complications and/or treatment and potential risk factors for infantile hemangioma were analyzed by logistic regression.

RESULTS

The clinical features of our study patients were different from those of other race/ethnicity groups reported by previous studies with regard to the morphologic subtypes, complications, and predictors for complications and/or oral corticosteroid treatment. After adjustment, significant risk factors for hemangiomas included lower level of maternal education (odds ratio [OR], 0.61; 95% confidence interval [CI], 0.57-0.66), mother engaged in manual labor (OR, 1.29; 95% CI, 1.12-1.48), multiple gestation (OR, 1.20; 95% CI,1.05-1.36), maternal medication use during the periconceptional period (OR, 2.08; 95% CI, 1.88-2.31), and a positive family history of hemangiomas (OR, 1.55; 95% CI, 1.40-1.72).

CONCLUSION

Besides yielding several new findings with respect to risk factors for hemangiomas, the current study also suggests that the Chinese clinical features of hemangiomas are somewhat different epidemiologically from those in the West.

摘要

目的

研究中国婴幼儿血管瘤的人口统计学和临床特征;更详细地了解该疾病发生的危险因素;并确定与并发症、相关风险以及全身治疗需求相关的临床特征。

设计

一项病例对照研究,纳入了1832名前瞻性招募的血管瘤患儿,并选取了1832名年龄、性别、地区匹配且于2005年至2008年期间在皮肤科就诊的对照儿童。

地点

中国中南部的两家大型医院。

患者

共1832名血管瘤患儿。

主要观察指标

总结人口统计学和临床表现,并与既往血管瘤研究的数据进行比较。通过逻辑回归分析并发症和/或治疗的预测临床因素以及婴幼儿血管瘤的潜在危险因素。

结果

在形态学亚型、并发症以及并发症和/或口服糖皮质激素治疗的预测因素方面,本研究患者的临床特征与既往研究报道的其他种族/民族群体不同。调整后,血管瘤的显著危险因素包括母亲受教育程度较低(比值比[OR],0.61;95%置信区间[CI],0.57 - 0.66)、母亲从事体力劳动(OR,1.29;95% CI,1.12 - 1.48)、多胎妊娠(OR,1.20;95% CI,1.05 - 1.36)、孕前期母亲用药(OR,2.08;95% CI,1.88 - 2.31)以及血管瘤家族史阳性(OR,1.55;95% CI,1.40 - 1.72)。

结论

除了得出关于血管瘤危险因素的若干新发现外,本研究还表明,血管瘤的中国临床特征在流行病学上与西方有所不同。

相似文献

1
Demographic and clinical characteristics and risk factors for infantile hemangioma: a Chinese case-control study.婴儿血管瘤的人口统计学和临床特征及危险因素:一项中国病例对照研究。
Arch Dermatol. 2011 Sep;147(9):1049-56. doi: 10.1001/archdermatol.2011.122. Epub 2011 May 16.
2
Clinical characteristics and risk factors for infantile hemangioma--a case control study.婴儿血管瘤的临床特征及危险因素——一项病例对照研究
Eur J Pediatr Surg. 2014 Feb;24(1):102-12. doi: 10.1055/s-0033-1354581. Epub 2013 Sep 5.
3
Growth characteristics of infantile hemangiomas: implications for management.婴儿血管瘤的生长特征:对治疗的启示
Pediatrics. 2008 Aug;122(2):360-7. doi: 10.1542/peds.2007-2767.
4
Infantile hemangiomas with minimal or arrested growth: a retrospective case series.生长缓慢或停止生长的婴幼儿血管瘤:一项回顾性病例系列研究
Arch Dermatol. 2010 Sep;146(9):971-6. doi: 10.1001/archdermatol.2010.197.
5
Infantile hemangiomas and retinopathy of prematurity: possible association.婴儿血管瘤与早产儿视网膜病变:可能的关联。
Pediatrics. 2009 Mar;123(3):e484-9. doi: 10.1542/peds.2007-0803. Epub 2009 Feb 16.
6
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.1998 - 2001年美国6至59个月大儿童的百日咳疫苗效力
Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759.
7
Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas.皮肤和气道血管瘤中PHACE综合征的临床谱及风险
Arch Otolaryngol Head Neck Surg. 2011 Jul;137(7):680-7. doi: 10.1001/archoto.2011.113.
8
Prospective study of spinal anomalies in children with infantile hemangiomas of the lumbosacral skin.腰骶部皮肤婴幼儿血管瘤患儿脊柱异常的前瞻性研究。
J Pediatr. 2010 Nov;157(5):789-94. doi: 10.1016/j.jpeds.2010.07.054. Epub 2010 Sep 9.
9
Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas.先天性血管瘤:快速消退型和非消退型先天性血管瘤。
Arch Facial Plast Surg. 2005 Sep-Oct;7(5):307-11. doi: 10.1001/archfaci.7.5.307.
10
Propranolol in the management of airway infantile hemangiomas.普萘洛尔用于气道婴儿血管瘤的治疗
Arch Otolaryngol Head Neck Surg. 2010 Jul;136(7):658-65. doi: 10.1001/archoto.2010.92.

引用本文的文献

1
Infantile hemangiomas: a dermatologist's perspective.婴幼儿血管瘤:皮肤科医生的视角。
Eur J Pediatr. 2024 Oct;183(10):4159-4168. doi: 10.1007/s00431-024-05655-8. Epub 2024 Jul 25.
2
A multi-step approach to the treatment of giant scalp congenital hemangiomas: a report of two cases.巨大头皮先天性血管瘤治疗的多步骤方法:两例报告
Front Surg. 2023 May 24;10:1045285. doi: 10.3389/fsurg.2023.1045285. eCollection 2023.
3
Racial discrepancies in presentation of hospitalized infantile hemangioma cases using the Kids' Inpatient Database.
利用儿童住院数据库分析住院婴儿血管瘤病例表现中的种族差异。
Health Sci Rep. 2023 Jan 30;6(2):e1092. doi: 10.1002/hsr2.1092. eCollection 2023 Feb.
4
Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size.婴儿血管瘤的母婴及围产期危险因素:一项大样本匹配病例对照研究
Dermatol Ther (Heidelb). 2022 Jul;12(7):1659-1670. doi: 10.1007/s13555-022-00756-4. Epub 2022 Jun 25.
5
Update on Treatment of Infantile Hemangiomas: What's New in the Last Five Years?婴儿血管瘤治疗的最新进展:过去五年有哪些新变化?
Front Pharmacol. 2022 May 26;13:879602. doi: 10.3389/fphar.2022.879602. eCollection 2022.
6
Infantile hepatic hemangiomas: looking backwards and forwards.婴儿肝血管瘤:回顾与展望
Precis Clin Med. 2022 Feb 11;5(1):pbac006. doi: 10.1093/pcmedi/pbac006. eCollection 2022 Mar.
7
Infantile Hemangioma: A Review of Current Pharmacotherapy Treatment and Practice Pearls.婴儿血管瘤:当前药物治疗及实用要点综述
J Pediatr Pharmacol Ther. 2020;25(7):586-599. doi: 10.5863/1551-6776-25.7.586.
8
Temporal trends in prenatal risk factors for the development of infantile hemangiomas.婴儿血管瘤发生的产前危险因素的时间趋势。
Pediatr Dermatol. 2018 Nov;35(6):787-791. doi: 10.1111/pde.13659. Epub 2018 Sep 6.
9
Adult neck hemangiolymphangioma: a case and review of its etiology, diagnosis and management.成人颈部血管淋巴管瘤:1例病例及病因、诊断与治疗的文献复习
J Surg Case Rep. 2017 Aug 31;2017(8):rjx168. doi: 10.1093/jscr/rjx168. eCollection 2017 Aug.
10
Management of infantile hemangiomas: current trends.婴儿血管瘤的管理:当前趋势
J Cutan Aesthet Surg. 2014 Apr;7(2):75-85. doi: 10.4103/0974-2077.138324.